Nectar Medipharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 25 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 22.19%
(FY 2022)
- Profit 111.25%
(FY 2022)
- Ebitda -143.73%
(FY 2022)
- Net Worth 4.49%
(FY 2022)
- Total Assets 9.42%
(FY 2022)
About Nectar Medipharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayendra Desai, Gunjan Desai, Ashish Desai, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232MH1999PTC243788
- Company No.
243788
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 1999
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nectar Medipharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayendra Desai  | Director | 19-Nov-2020 | Current |
| Gunjan Desai | Director | 14-Oct-2014 | Current |
| Ashish Desai | Director | 14-Jul-2011 | Current |
| Kruti Bathia | Director | 15-Jan-2015 | Current |
| Shweta Sanghavi | Director | 15-Jan-2015 | Current |
Financial Performance of Nectar Medipharma.
Nectar Medipharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.19% increase. The company also saw a substantial improvement in profitability, with a 111.25% increase in profit. The company's net worth moved up by a moderate rise of 4.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nectar Medipharma?
In 2019, Nectar Medipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bhavya Containers Private LimitedActive 2 years 7 months
Jayendra Desai, Gunjan Desai and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nectar Medipharma?
Unlock and access historical data on people associated with Nectar Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nectar Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nectar Medipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
